1. Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with COVID-19 pneumonia.
- Author
-
De Biasi S, Meschiari M, Gibellini L, Bellinazzi C, Borella R, Fidanza L, Gozzi L, Iannone A, Lo Tartaro D, Mattioli M, Paolini A, Menozzi M, Milić J, Franceschi G, Fantini R, Tonelli R, Sita M, Sarti M, Trenti T, Brugioni L, Cicchetti L, Facchinetti F, Pietrangelo A, Clini E, Girardis M, Guaraldi G, Mussini C, and Cossarizza A
- Subjects
- Adult, Aged, Aged, 80 and over, Biomarkers metabolism, CD4-Positive T-Lymphocytes metabolism, CD4-Positive T-Lymphocytes pathology, CD8-Positive T-Lymphocytes metabolism, CD8-Positive T-Lymphocytes pathology, COVID-19, Cellular Senescence, Coronavirus Infections blood, Coronavirus Infections pathology, Cytokine Release Syndrome, Cytokines immunology, Cytokines metabolism, Female, Humans, Immunologic Memory, Italy epidemiology, Lymphocyte Activation, Lymphocyte Count, Male, Middle Aged, Pandemics, Pneumonia, Viral blood, Pneumonia, Viral pathology, SARS-CoV-2, T-Lymphocyte Subsets metabolism, T-Lymphocyte Subsets pathology, Th17 Cells immunology, Th17 Cells metabolism, Th17 Cells pathology, Betacoronavirus immunology, CD4-Positive T-Lymphocytes immunology, CD8-Positive T-Lymphocytes immunology, Coronavirus Infections immunology, Pneumonia, Viral immunology, T-Lymphocyte Subsets immunology
- Abstract
The immune system of patients infected by SARS-CoV-2 is severely impaired. Detailed investigation of T cells and cytokine production in patients affected by COVID-19 pneumonia are urgently required. Here we show that, compared with healthy controls, COVID-19 patients' T cell compartment displays several alterations involving naïve, central memory, effector memory and terminally differentiated cells, as well as regulatory T cells and PD1
+ CD57+ exhausted T cells. Significant alterations exist also in several lineage-specifying transcription factors and chemokine receptors. Terminally differentiated T cells from patients proliferate less than those from healthy controls, whereas their mitochondria functionality is similar in CD4+ T cells from both groups. Patients display significant increases of proinflammatory or anti-inflammatory cytokines, including T helper type-1 and type-2 cytokines, chemokines and galectins; their lymphocytes produce more tumor necrosis factor (TNF), interferon-γ, interleukin (IL)-2 and IL-17, with the last observation implying that blocking IL-17 could provide a novel therapeutic strategy for COVID-19.- Published
- 2020
- Full Text
- View/download PDF